Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 562,550 |
|
|||||
| News | - | ||||||
| Day High | 2.81 | Low High |
|||||
| Day Low | 2.73 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mereo BioPharma Group PLC | MREO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.07 | -2.49% | 2.74 | 16:32:57 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.81 | 2.73 | 2.81 | 2.74 | 2.81 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,351 | 562,550 | US$ 2.77 | US$ 1,558,716 | - | 0.9201 - 4.36 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:11:02 | formt | 1,435 | US$ 2.75 | USD |
Mereo BioPharma Group PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 140.18M | - | 811k | -34.2M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mereo BioPharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MREO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.62 | 2.885 | 2.53 | 2.76 | 909,467 | 0.12 | 4.58% |
| 1 Month | 3.35 | 3.48 | 2.525 | 2.92 | 899,893 | -0.61 | -18.21% |
| 3 Months | 3.93 | 4.36 | 2.525 | 3.43 | 1,273,934 | -1.19 | -30.28% |
| 6 Months | 1.70 | 4.36 | 1.59 | 3.06 | 1,327,569 | 1.04 | 61.18% |
| 1 Year | 1.14 | 4.36 | 0.9201 | 2.11 | 1,467,380 | 1.60 | 140.35% |
| 3 Years | 3.42 | 4.36 | 0.301 | 1.75 | 1,451,008 | -0.68 | -19.88% |
| 5 Years | 5.92 | 6.28 | 0.301 | 2.16 | 1,149,070 | -3.18 | -53.72% |
Mereo BioPharma Description
| Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. |
